Cargando…
Analysis of patient’s X-ray exposure in hepatic chemosaturation procedures: a single center experience
BACKGROUND: Hepatic chemosaturation is a technique in which a high dose of the chemotherapeutic agent melphalan is administered directly into the liver while limiting systemic side effects. We reviewed our institutional experience regarding patient’s X-ray exposure caused by the procedure. METHODS:...
Autores principales: | Ebel, Sebastian, Reinhardt, Martin, Beeskow, Anne Bettina, Teske, Felix, Struck, Manuel Florian, Veelken, Rhea, van Boemmel, Florian, Berg, Thomas, Moche, Michael, Gutberlet, Matthias, Gößmann, Holger, Denecke, Timm |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469537/ https://www.ncbi.nlm.nih.gov/pubmed/36100850 http://dx.doi.org/10.1186/s12880-022-00887-2 |
Ejemplares similares
-
Prognostic Factors for Postoperative Bleeding Complications and Prolonged Intensive Care after Percutaneous Hepatic Chemosaturation Procedures with Melphalan
por: Struck, Manuel Florian, et al.
Publicado: (2023) -
Anästhesiologisches und postinterventionelles Management bei perkutaner hepatischer Melphalanperfusion (Chemosaturation)
por: Kliem, Peter, et al.
Publicado: (2022) -
Percutaneous hepatic melphalan perfusion: Single center experience of procedural characteristics, hemodynamic response, complications, and postoperative recovery
por: Struck, Manuel Florian, et al.
Publicado: (2021) -
Repeated percutaneous hepatic perfusion with melphalan can maintain long-term response in patients with liver cancers
por: Veelken, Rhea, et al.
Publicado: (2021) -
The Liver Maximum Capacity Test (LiMAx) Is Associated with Short-Term Survival in Patients with Early Stage HCC Undergoing Transarterial Treatment
por: Fischer, Janett, et al.
Publicado: (2022)